Abbvie Inc.

Tianli Wang

Wei Liu

Sandeep Dutta

Walid M Awni

Sven Mensing

Barry M Bernstein

Rajeev M Menon

Thomas J Podsadecki

Chih-Wei Lin

Andrew L Campbell

The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.

Methods for treating HCV

Method for treating HCV

Growing community of inventors

Lake Bluff, IL, United States of America

Tianli Wang